Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-745-2535
Dr. Miranda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematopathology, 1995 - 1998
Rhode Island Hospital/Brown University HealthResidency, Pathology-Anatomic and Clinical, 1991 - 1995
Cayetano Heredia UniversityClass of 1983
Certifications & Licensure
TX State Medical License 2007 - 2027
PA State Medical License 1995 - 2004
FL State Medical License 1978 - 1981
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib.Carlos A Torres-Cabala, Julia Arreola Yescas, Yue Zhang, Auris Huen, Gaur Sumit
Blood Advances. 2025-04-22 - Nucleolated cells in extranodal marginal zone lymphoma: a case report and discussion of circulating lymphoma cells with prominent nucleoli.Beatriz Rocha-Rodrigues, Roberto N Miranda, L Jeffrey Medeiros
Journal of Hematopathology. 2025-04-12 - Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review.Karen Amelia Nahmod, Roberto N Miranda, Francisco Vega, Beenu Thakral, Naveen Pemmaraju
Leukemia & Lymphoma. 2025-04-01
Journal Articles
- Breast Implant-Associated Anaplastic Large Cell Lymphoma: A ReviewL Jeffrey Medeiros, Mark W Clemens, Roberto N Miranda, Nature
Abstracts/Posters
- MYC Expression in Systemic Anaplastic Large Cell Lymphoma: Clinicopathologic and Prognostic Features of 70 PatientsRoberto N. Miranda, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase I/II Study to Examine the Safety and Efficacy of Pembrolizumab 200 Mg Fixed Dose Administered Every 3 Weeks (Q3W) in Combination with Romidepsin in Relapsed or...Roberto N. Miranda, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Roberto N. Miranda, MD, a Pathologist and Hematopathologist in TexasOctober 18th, 2019
Breast Implant-Associated Lymphoma on the RiseApril 11th, 2019
Miranda RN, Clemens MW (2018) Letter to the Editor Regarding: Fleming D, Stone J, Tansley P. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management...June 11th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
